glutathione and targeting cancer cells responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Targeting the Vulnerability of Glutathione
Targeting the Vulnerability of Glutathione Metabolism in ARID1A Deficient Cancers ScienceDirect Glutathione dependent degradation of SMARCA2 4 for targeted lung cancer therapy with improved selectivity ScienceDirect Glutathione Dependent Pathways in Cancer Cells Glutathione metabolism in cancer progression and treatment resistance PMC
Pay in 4 interest-free payments of $5.73 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23



